Paul M. Lehrer
Department of Psychiatry, University of Medicine and Dentistry of New Jersey--Robert Wood Johnson Medical School, Piscataway, New Jersey
Key words: multiple chemical sensitivity, psychophysiology, individual response stereotypy, situational response specificity, active and passive coping, perception, psychophysics, suggestion, conditioning, panic
This paper is based on a presentation at the Conference on Experimental Approaches to Chemical Sensitivity held 20-22 September 1995 in Princeton, New Jersey. Manuscript received at EHP 6 March 1996; manuscript accepted 4 September 1996.
The author is grateful to R. Carr, N. Giardino, and H. Kipen for comments on earlier drafts of this paper.
Address correspondence to Dr. P.M. Lehrer, Department of Psychiatry, Robert Wood Johnson Medical School, 671 Hoes Lane, Piscataway, NJ 08854. Telephone: (908) 235-4413. Fax: (908) 235-5158. E-mail: lehrer@umdnj.edu
Abbreviations used: CNS, central nervous system; HR, heart rate; MCS, multiple chemical sensitivity.
First, conducting research on possible psychological or psychophysiological contributions to MCS does not imply that MCS is entirely or primarily psychological. Scientific investigation is neutral on the topic. If psychological factors play no role or a minimal role in MCS, a program of good research will be able to establish this firmly. If psychological factors do play a part, then understanding them can only help in the prevention and treatment of this debilitating problem.
Second, if psychological factors are found to play an important role in MCS, this does not necessarily imply that the problem is imaginary. The distinction between psychological and somatic disorders has become blurred in recent years. It is well known that psychological factors can exacerbate a variety of somatic diseases, including headache (1-3), ischemic heart disease (4), cancer (5,6), Raynaud's disease (7), rheumatoid arthritis (8), asthma (9), irritable bowel syndrome (10), chronic pain (11), and even some infectious diseases (12). The role of psychological factors in exacerbation of these diseases has been firmly established. Some evidence also exists for a possible contributing role in diathesis.
Conversely, some psychological disorders are known to be triggered by physical ailments that produce similar symptoms. For example, panic disorder and other anxiety disorders have a statistical relationship with the presence of such disorders as mitral valve prolapse (13), hyperthyroidism (14), irritable bowel syndrome (15,16), and asthma (17,18). Although no firm evidence exists regarding the direction of causality, several theories have been proposed implicating these physical disorders as causal factors in panic disorder. Also, psychological disorders including anxiety and depression have been linked to particular kinds of brain pathology, such as depressed levels of serotonin and various structural abnormalities (19,20). So even some purely psychological disorders have physiological bases. If a chemical exposure adversely affects the central nervous system, some of the resulting symptoms may look like mental disorders.
Third, finding an important role for psychological procedures in treating MCS does not necessarily exclude the possibility that the disorder is organic in origin. This is true even if these psychological procedures are as effective or more effective than various medical interventions. For example, this is the case for muscle contraction (21) and migraine headaches (22,23), irritable bowel syndrome (24,25), and Raynaud's disease (26). Psychological components in treatment programs have proven effective for hypertension (27), cancer (28,29), and epilepsy (30), to name a few. If exposure to chemicals is a psychological stressor among MCS patients (probably in addition to being a physical trigger of symptoms), a stress-related autonomic reaction also may occur, perhaps superimposed on other physical reactions.
This paper reviews some of the psychophysiological research paradigms that have been used to describe human psychophysiological response to various kinds of stimulation. If neuropsychological factors play any role in MCS, their influence may be measured by research using some of these paradigms.
Not everyone shows individual response stereotypy, but some do to a marked extent. It has been hypothesized that in some cases stereotypy may predispose an individual to psychosomatic disease (32). Consistent with this, individuals with family histories of hypertension (and who therefore may have a physiological predisposition to hypertension) tend to show greater cardiovascular reactivity to a variety of laboratory stressors (33). Similarly, asthmatics have been found to react to a variety of stressors with bronchoconstriction (34) and muscle contraction headache patients react with tension in the skeletal muscles of the face and shoulders, etc. (35). It is possible that severe chemical exposure may act as an unconditional stimulus, producing one-trial learning of a conditioned neuropsychological response. It may have a particular sensitizing effect upon individuals who are predisposed to stereotypic psychophysiological responsiveness (e.g., in the lung or the nose) even before exposure. Later this same physiological response may generalize and be elicited by other substances. In this stage it may also be elicited in response to psychological stressors.
In some people response to chemical exposure may be in the cardiovascular system (palpitations, faintness), in some cases in the respiratory system (wheezing or mucous secretions), and in some cases such chemical exposure may cause nausea, inflammation, fever, fatigue, muscular aches and pains, weakness, or perhaps psychological symptoms such as confusion, anxiety, or depression. After chemical exposure, it is possible that the body's self-regulatory system is compromised, so exposure to various kinds of stressors, particularly chemical ones, produces a stereotyped physiological stress response in this subpopulation. To the extent that this response may be mediated in part by the central nervous system(CNS), psychological factors may be involved.
Situational Response Specificity
Some tasks elicit characteristic physiological responses (31). For example, tasks eliciting an attitude of active coping tend to produce a particular response characterized by beta sympathetic activation: increased heart rate and systolic blood pressure, bronchodilation, and increased ventilation (36-39). Aversive tasks associated with a more passive response (e.g., watching a scary film) tend to elicit responses such as alpha sympathetic activation (peripheral vasoconstriction), increased cardiotropic parasympathetic activity, and bronchoconstriction (40-42).
If exposure to chemicals is a psychological stressor among MCS patients (in addition to possibly being a physical trigger of symptoms), a stress-related autonomic reaction also may occur, perhaps superimposed on other physical reactions. If exposure cannot be avoided, we might expect the psychological component of the response to be similar to the passive coping profile: faintness, increased vagal tone, and asthmalike symptoms. On the other hand, if the individual finds the exposure situation aversive and can avoid it, the response may include rapid heartbeat and perhaps palpitations, bronchodilation, and increased ventilation. These all are common symptoms in MCS. According to this theory, however, if the situation is not perceived to be aversive, no observable autonomic response is expected except that directly produced by the chemical (which should be observable in people without MCS and in lower animals).
There is also evidence that exposure to stimuli previously associated with chemical exposure can produce a strong conditioned psychophysiologial response specific to the particular chemical (43). Siegel has hypothesized that this response is adaptive in that it may prepare the body for dealing with oncoming chemical exposure more effectively (43). Thus, as observed in everyday situations, the sight and smell of food elicits various changes in the gastrointestinal tract. Aromas, sights, and sounds associated with a particular place immediately elicit thoughts and often feelings and desires. Perfume elicits such powerful emotional responses that major industries have been capitalizing for centuries on pronounced psychophysiologial effects of chemicals in the air. It is possible that through psychological conditioning such exposures might also elicit physiological reactions that could explain at least some of the symptoms of MCS.
Some specific symptoms of disease can even be triggered by suggestion. In the asthma literature a number of studies have provided evidence that psychogenic asthma attacks can occur even when a person simply thinks that exposure to an asthma trigger has occurred. The typical experimental paradigm here involves telling the asthmatic subject that (s)he is being exposed to an asthma trigger (an allergen or a bronchoconstrictor), and then subjecting the person to a convincing exposure of an inert substance (e.g., nebulized saline or just room air); the subject believes that (s)he has been exposed to a nebulized bronchoconstrictor. Among some asthmatics (between 1 in 4 and 1 in 20, depending on the study), a clinically significant bronchoconstriction occurs (34). Similarly, bronchodilation may occur in some subjects when they believe they are being exposed to a bronchodilator (44). Clinically significant bronchoconstriction responses tend not to occur in nonasthmatics, although brief and small but statistically significant responses sometimes occur in this group as well. (45).
Relationship between Individual Response Stereotypy, Stimulus Response Specificity, and Psychosomatic Disease
It is possible that psychosomatic disease may occur when a person with a tendency toward individual response stereotypy is repeatedly exposed over long periods of time to situations that also specifically evoke that person's characteristic response. Under such circumstances, the body may change its homeostatic set point, or it may continually return to a level of physiological arousal that may be maladaptive in other respects. Alternatively, the organism may become overly sensitized to particular types of stimulation and thus may overreact to stimulation that ordinarily would evoke no response. Such sensitization may occur either after repetitive stimulation or even after a single mass exposure, as in traumatic conditioning, particularly where the organism is preprogrammed to develop such a response. The concept of biological prepotency or preparedness has been used to describe the tendency for certain biologically relevant stimuli to be more powerful than others as nonhabituating and/or conditional stimuli (46). Although biological prepotency does not explain much variance in development of human phobias, as originally hypothesized (47) it is possible that certain types of chemical stimulation may be found to be prepotent in this way. Thus, we might hypothesize that MCS patients, whose systems are highly attuned to cues of chemical exposure, show a similar psychophysiologial sensitization to olfactory cues of chemical exposure after repeated or traumatic exposure. The critical factor distinguishing such reactions from nonpsychological sensitization reactions (e.g., as may occur in allergies) is the role of the central nervous system and psychological experience in producing the effects.
Effects of Cognitive Style
Research on coping with stress suggests that the cognitive orientation of the individual toward stressful stimulation has a measurable and reliable effect on physiological response (48). It is reasonable, therefore, to hypothesize that this is also true when stimulation is in the form of aversive chemical exposure. Some individuals may interpret chemical exposure as aversive, unavoidable, and inescapable, and thus exhibit a passive coping response. In such cases, symptoms of faintness and dyspnea may prevail because of increased vagal tone and bronchoconstriction. Others may experience palpitations and discomfort associated with muscle tension, because they experience the stimulation as a "call to action." Still others may not consider exposure aversive, and so exhibit no emotionally induced physiological response.
Magnitude Estimation
Magnitude estimation would involve exposing MCS patients to various quantities of inhaled chemicals and then asking them to rate the relative magnitude of the exposures. This can be done by asking patients to give a number proportional to the amount of exposure relative to a standard stimulus of exposure. The usual metric associated with this method is the slope of the gain in perception of intensity relative to the gain in actual exposure. Individuals who are more sensitive to stimulation would have higher slopes, usually after data are converted to a log-log function, to account for the expected curvilinearity in all modes of perception.
In addition, the aversiveness associated with exposure can be quantified. Based on previous research on pain and on asthma, it would be useful to measure relevant dimensions of the chemical-induced symptoms. It is known that most physical symptoms have two independent dimensions: intensity and unpleasantness. Of these, the intensity dimension tends to be more closely related to physical intensity of stimulation, whereas unpleasantness is related to the subject's emotional reaction to the stimulation. These two dimensions have been documented in laboratory studies of experimentally induced pain (50) and dyspnea (51). Tursky et al. (50) developed the Pain Perception Profile, a verbal rating scale for psychophysical estimate of pain. We have adapted it for assessment of dyspnea in asthma (51). If MCS individuals experience greater discomfort than others but similar levels of perception, this provides some evidence that central nervous system centers involving emotional reactivity (e.g., limbic centers) are sensitized in this population or perhaps that endorphin levels, which may mitigate feelings of discomfort, are particularly low in this population. If sensitivity to the magnitude of the stimulation is elevated among MCS patients, it is possible that sensory nerves and reflexes associated with sensation may be more active among MCS patients. Data from our laboratory suggest that psychological factors may have a greater impact on perception of the unpleasantness of a stimulation than in perception of the magnitude or intensity of the stimulus (52).
Threshold Detection
Another method for quantifying perceptual sensitivity to stimulation is threshold detection. In this procedure the intensity of exposure in gradually increased to the point at which the individual first feels something. This point is the threshold of detection. Threshold detection studies also can determine the threshold for detecting a "just noticeable difference" in exposure. If MCS patients have lower absolute and difference thresholds than other subjects, it is possible that they are more tuned to reacting to this type of stimulation. Differences in sensitivity may reflect either physiological processes (e.g., greater sensory receptor sensitivity) or psychological processes (e.g., greater alertness to chemical stimulation). A single study by Doty et al. (53) found no differences between MCS patients and normal individuals in the threshold for detecting the odor of phenyl ethyl alcohol and methyl ethyl ketone, but throughout the testing session MCS patients were found to have higher nasal resistances, respiration rates, and Beck Depression inventory scores. These data suggest that MCS patients may not be perceptually more sensitive to odors than other subjects, but they generally exhibit greater depression and decreased nasal patency.
Method of Production
Instead of responding verbally in threshold detection tasks, individuals can self-administer stimulation and stop the stimulation when they have reached a threshold of detection. This method can be used in conjunction with the magnitude estimation method; i.e., subjects can estimate the magnitude of discomfort. In one study, our laboratory used this method with patients suffering from muscle contraction headaches (54). A tourniquet was tied around their upper arms and subjects were asked to pump a ball until they began to feel discomfort, then pain, then pain sufficient to make them want to stop pumping. (To prevent subjects from harming themselves they were not permitted to do this task for more than 1.5 min.) We found that headache patients detected discomfort and pain within shorter time periods than other subjects but reported the pain to be more intense than did the other subjects. This suggested that headache pain patients were more sensitive than others to forms of ischemic pain in areas other than the head.
A tendency to hyperventilate can be measured noninvasively by measuring end-tidal CO2, via a small tube placed at the end of the nostril. A decrease in petCO2 might be expected after chemical exposure among individuals who hyperventilate and may indicate an emotional response to such stimulation. Although the existence of such a response would not indicate that the symptoms of MCS are necessarily caused by a hyperventilation response (because correlation cannot prove causation), lack of correlation could rule out stimulus-induced hyperventilation as a mediating variable in MCS.
In addition to petCO2, other respiratory measures may provide useful information. Measures of respiratory resistance can assess responses involving bronchodilation or bronchoconstriction. Bronchodilation may predispose a person to hyperventilate, whereas bronchoconstriction may produce some asthmalike symptoms. If MCS patients react bronchially more to psychological stress than other individuals, it is possible that this response may contribute to some of the symptoms of MCS.
Assessing respiratory drive after exposure to various chemical stressors also would assess the possibility of an augmented respiratory response. Asthmatics tend to show a greater increase in inspiratory effort in response to breathing through external resistors than do other individuals, and panic disorder patients show greater inspiratory pressure responses in response to breathing CO2. If MCS patients show greater increases in respiratory drive than others when exposed to noxious chemicals, this would also suggest that some symptoms of MCS may result from hyperventilation.
2. Ehde DM, Holm JE. Stress and headache: comparisons of migraine, tension, and headache-free subjects. Headache Quar 3:54-60 (1992).
3. Holm JE, Holroyd KA, Hursey KG, Penzien DB. The role of stress in recurrent tension headache. Headache 26:160-167 (1986).
4. Siegman AW, Smith TW. Anger, Hostility and the Heart. Hillsdale, NJ:Lawrence Erlbaum Associates, 1994.
5. Baltrusch HJ, Stangel W, Titze I. Stress, cancer and immunity. New developments in biopsychosocial and psychoneuroimmunologic research. Acta Neurologica 13:315-327 (1991).
6. Temoshok L. Personality coping style emotion and cancer: towards an integrative model. Cancer Surveys 6:545-567 (1987).
7. Freedman RR, Ianni P. Role of cold and emotional stress in Raynaud's disease and scleroderma. Br Med J Clin Res 287:1499-1502 (1983).
8. Zautra AJ, Burleson MH, Matt KS, Roth S, Burrows L. Interpersonal stress depression and disease activity in rheumatoid arthritis and osteoarthritis patients. Health Psychol 13:139-148 (1994).
9. Lehrer PM, Isenberg S, Hochron S. Asthma and emotion: a review. J Asthma 30:5-21 (1993).
10. Blanchard EB, Schwarz SP, Radnitz C. Psychological assessment and treatment of irritable bowel syndrome. Behav Modif 11:348-372 (1987).
11. Hanson RW, Gerber KE. Coping with Chronic Pain: A Guide to Patient Self-management. New York:Guilford Publications, 1990.
12. Cohen S, Williamson GM. Stress and infectious disease in humans. Psychol Bull 109:5-24 (1991).
13. Bowen RC, D'Arcy C, Orchard RC. The prevalence of anxiety disorders among patients with mitral valve prolapse syndrome and chest pain. Psychosomatics 32:400-406 (1991).
14. Rodewig K. Psychosomatic aspects of hyperthyroidism with special reference to Basedow's disease. An overview. Psychother Psychosom Med Psychol 43:271-273 (1993).
15. Nyhlin H, Ford MJ, Smith JH, Nicol EF, Elton RA, Eastwood MA. Non-alimentary aspects of the irritable bowel syndrome. J Psychosom Res 37:155-162 (1993).
16. Woodman CL, Noyes R. The relationship between panic disorder and irritable bowel syndrome. A review. Ann Clin Psychiat 4:175-180 (1992).
17. Carr RE, Lehrer PM, Hochron SM. Panic symptoms in asthma and panic disorder: a preliminary test of the dyspnea-fear theory. Behav Res Ther 30:251-261 (1992).
18. Yellowlees PM, Haynes S, Potts N, Ruffin RE. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aus 146:305-307 (1987).
19. Hesselink JMK. Serotonin, depression, and panic disorder. Neurology 43:1624-1625 (1993).
20. Sheehan DV, Raj BA, Trehan RR, Knapp EL. Serotonin in panic disorder and social phobia. Int Clin Psychopharmacol 8(Suppl 2): 63-77 (1993).
21. Blanchard EB, Appelbaum KA, Guarnieri P, Morrill B, Dentinger MP. Five year prospective follow-up on the treatment of chronic headache with biofeedback and/or relaxation. Headache 27:580-583 (1987).
22. Blanchard EB, Appelbaum KA, Radnitz CL, Morrill B, Michultka D, Kirsch C, Guarnieri P, Hillhouse J, Evans D, Jaccard J, Barron K. A controlled evaluation of thermal biofeedback and thermal biofeedback combined with cognitive therapy in the treatment of vascular headache. J Consult Clin Psychol 58:216-224 (1990).
23. Lisspers J, Öst LG. Long-term follow-up of migraine treatment: do effects remain up to six years? Behav Res Ther 28:313-322 (1990).
24. Blanchard EB, Schwarz SP. Adaptation of a multicomponent treatment for irritable bowel syndrome to a small-group format. Biofeed Self-Reg 12:63-69 (1987).
25. Blanchard EB, Schwarz SP, Suls JM, Gerardi MA, Scharff L, Greene B, Taylor A, Berreman C, Malamood H. Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome. Behav Res Ther 30:1751-1789 (1992).
26. Freedman R. Long-term effectiveness of behavioral treatment of Raynaud's disease. Behav Ther 18:387-399 (1987).
27. Patel C, Marmot M, Terry D, Corruthers M, Hunt B, Patel M. Trial of relaxation in reducing coronary risk: four year follow up. Br Med J 13:1103-1106 (1985).
28. Sampson CC. Management of cancer pain: guideline overview. J Natl Med Assoc 86:571-573 (1994).
29. Stolbach LL, Lorman CE. Further comments on counseling people with cancer: pursuing the perfect paradigm. Advances 10:57-58 (1994).
30. Sterman MB. Epilepsy and its treatment with EEG biofeedback. Ann Behav Med 8:21-25 (1986).
31. Andreassi JL. Psychophysiology: Human Behavior and Physiological Response. Hillsdale, NJ:Lawrence Erlbaum Associates, 1989.
32. Engel BT, Moos RH. The generality of specificity. Arch Gen Psychiat 16: 574-581 (1967).
33. Saab PG, Schneiderman N. Biobehavioral stressors, laboratory investigation, and the risk of hypertension. In: Cardiovascular Reactivity to Psychological Stress and Disease (Blascovich J, Katkin ES, eds). Washington:American Psychological Association, 1993;49-82.
34. Isenberg SA, Lehrer PM Hochron, S. The effects of suggestion and emotional arousal on pulmonary function in asthma: a review. Psychosom Med 54:192-216 (1992).
35. Malmo RB, Shagass C. Physiologic study of symptom mechanisms in psychiatric patients under stress. Psychosom Med 11:25-29 (1949).
36. Grossman P, Svebak S. Respiratory sinus arrhythmia as an index of parasympathetic cardiac control during active coping. Psychophysiology 24:228-235 (1987).
37. Hasenfratz M, Battig K. Psychophysiological reactions during active and passive stress coping following smoking cessation. Psychopharmacology 104:356-362 (1991).
38. Johnston DW, Anastasiades P, Wood C. The relationship between cardiovascular responses in the laboratory and in the field. Psychophysiology 27:34-44 (1990).
39. Tanaka G. The relationships between sympathetic and parasympathetic tones and cardiovascular responses during active coping. Jap J Psychol 63:92-99 (1992).
40. Boiten FA, Frijda NH. Emotions and respiratory patterns: review and critical analysis. Int J Psychophysiol 17:103-28 (1994).
41. Sherwood A, Dolan CA, Light KC. Hemodynamics of blood pressure responses during active and passive coping. Psychophysiology 27:656-668 (1990).
42. Thyer BA, Himle J, Curtis GC. Blood-injury-illness phobia: a review. J Clin Psychol 41:451-459 (1985).
43. Siegel S, Krank MD, Hinson RE. Anticipation of pharmacological and nonpharmacological events: classical conditioning and addictive behavior. J Drug Issues 17:83-110 (1987).
44. Luparello TJ, Leist N, Lourie CH, Sweet P. The interaction of psychologic stimuli and pharmacologic agents on airway reactivity in asthmatic subjects. Psychosom Med 32:509-513 (1970).
45. Kotses H, Rawson JC, Wigal JK, Creer TL. Respiratory airway changes in response to suggestion in normal individuals. Psychosom Med 49:536-541 (1987).
46. Seligman ME. On the generality of the laws of learning. Psychol Rev 77:406-418 (1970).
47. McNally RJ. Preparedness and phobias: a review. Psychol Bull 101:283-303 (1987).
48. Lazarus RS. Psychological Stress and the Coping Process. New York:McGraw-Hill, 1966.
49. Stevens SS. Mathematics, measurement, and psychophysics. In: Handbook of Experimental Psychology (Stevens SS, ed). New York:Wiley, 1951;1-49.
50. Tursky B, Jamner LD, Friedman R. The Pain Perception Profile: a psychophysical approach to the assessment of pain report. Behav Ther 13:376-394 (1982).
51. Lehrer PM, Hochron SM, Isenberg S, Rausch L, Carr R. The Asthma Symptom Profile: a psychophysically based scale for assessment of asthma symptoms. J Psychosom Res 37:515-521 (1993).
52. Lehrer PM, Hochron S, Carr R, Edelberg R, Hamer R, Jackson A, Porges S. Behavioral task-induced bronchodilation in asthma during active and passive tasks: a possible cholinergic link to psychologically-induced airway changes. Psychosom Med 58:413-422 (1996).
53. Doty RL, Deems DA, Frye RE, Pelberg R, Shapiro A. Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Arch Otolaryngol Head Neck Surg 114:1422-1426 (1988).
54. Lehrer PM, Murphy AI. Stress reactivity and perception of pain among tension headache sufferers. Behav Res Ther 29:61-69 (1991).
55. Fried R. The Hyperventilation Syndrome. Baltimore:Johns Hopkins University Press, 1987.
Last Update: March 21, 1997